
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Fabio Fiorino, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 97
Annalisa Ciabattini, G Pastore, Fabio Fiorino, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 97
Showing 76-100 of 97 citing articles:
SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination
Tom Moore, Rojony Hossain, Katie J. Doores, et al.
Viral Immunology (2022) Vol. 35, Iss. 6, pp. 425-436
Open Access | Times Cited: 5
Tom Moore, Rojony Hossain, Katie J. Doores, et al.
Viral Immunology (2022) Vol. 35, Iss. 6, pp. 425-436
Open Access | Times Cited: 5
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
Immunogenicity and safety of heterologous booster with protein-based COVID-19 vaccine (NVX-CoV2373) in healthy adults: A comparative analysis with mRNA vaccines
Wang‐Huei Sheng, Pin‐Hung Lin, Yu‐Chen Cheng, et al.
Journal of the Formosan Medical Association (2023) Vol. 123, Iss. 3, pp. 340-346
Open Access | Times Cited: 2
Wang‐Huei Sheng, Pin‐Hung Lin, Yu‐Chen Cheng, et al.
Journal of the Formosan Medical Association (2023) Vol. 123, Iss. 3, pp. 340-346
Open Access | Times Cited: 2
COVID-19 vaccine booster induces a strong CD8+ T cell response against Omicron variant epitopes in HLA-A*02:01+ individuals
Andrea Nguyen, Christopher Szeto, Demetra S.M. Chatzileontiadou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Andrea Nguyen, Christopher Szeto, Demetra S.M. Chatzileontiadou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19 convalescents
Hao Wang, Yuan Yu, Bihao Wu, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 4, pp. 747-757
Open Access | Times Cited: 2
Hao Wang, Yuan Yu, Bihao Wu, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 4, pp. 747-757
Open Access | Times Cited: 2
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects
Giulia Brisotto, Marcella Montico, Matteo Turetta, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1276-1276
Open Access | Times Cited: 2
Giulia Brisotto, Marcella Montico, Matteo Turetta, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1276-1276
Open Access | Times Cited: 2
Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
(2024)
Closed Access
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
(2024)
Closed Access
Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections
Amin Alirezaylavasani, Linda Gail Skeie, Ingrid M. Egner, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Amin Alirezaylavasani, Linda Gail Skeie, Ingrid M. Egner, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Durability of Adaptive Immunity in Immunocompetent and Immunocompromised Patients Across Different Respiratory Viruses: RSV, Influenza, and SARS-CoV-2
Achilleas Livieratos, Lars Erik Schiro, Charalambos Gogos, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1444-1444
Open Access
Achilleas Livieratos, Lars Erik Schiro, Charalambos Gogos, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1444-1444
Open Access
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers
Federica Bergami, Francesca Arena, Josè Camilla Sammartino, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1809-1809
Open Access | Times Cited: 3
Federica Bergami, Francesca Arena, Josè Camilla Sammartino, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1809-1809
Open Access | Times Cited: 3
New approaches to vaccines for infectious diseases
Bagwe Priyal, Vijayanand Sharon, Patil Smital, et al.
Elsevier eBooks (2024), pp. 341-356
Closed Access
Bagwe Priyal, Vijayanand Sharon, Patil Smital, et al.
Elsevier eBooks (2024), pp. 341-356
Closed Access
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination
Valeriya Pozdnyakova, Brittany Weber, Susan Cheng, et al.
Rheumatic Disease Clinics of North America (2024) Vol. 51, Iss. 1, pp. 111-121
Closed Access
Valeriya Pozdnyakova, Brittany Weber, Susan Cheng, et al.
Rheumatic Disease Clinics of North America (2024) Vol. 51, Iss. 1, pp. 111-121
Closed Access
Response Rate to the 3rd and 4th Doses of BNT162b2 Vaccine in Cancer Patients Administered with Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
(2023)
Open Access | Times Cited: 1
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
(2023)
Open Access | Times Cited: 1
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 128-128
Open Access | Times Cited: 1
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 128-128
Open Access | Times Cited: 1
SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
Zhihua Fan, Shixin Duan, Fangfen Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1
Zhihua Fan, Shixin Duan, Fangfen Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1
Analysis of Antibodies Induced after SARS-CoV-2 Vaccination Using Antigen Coded Bead Array Luminex Technology
Zixuan Song, Qizhi Luo, Ling Wan, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 442-442
Open Access
Zixuan Song, Qizhi Luo, Ling Wan, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 442-442
Open Access
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination
Valeriya Pozdnyakova, Brittany Weber, Susan Cheng, et al.
Heart Failure Clinics (2023) Vol. 19, Iss. 2, pp. 177-184
Open Access
Valeriya Pozdnyakova, Brittany Weber, Susan Cheng, et al.
Heart Failure Clinics (2023) Vol. 19, Iss. 2, pp. 177-184
Open Access
Nanoscale Vaccines for the Prevention of COVID-19
Javid Iqbal Mir, Tooba Hamdani, Husain Attarwala, et al.
AAPS advances in the pharmaceutical sciences series (2023), pp. 367-402
Closed Access
Javid Iqbal Mir, Tooba Hamdani, Husain Attarwala, et al.
AAPS advances in the pharmaceutical sciences series (2023), pp. 367-402
Closed Access
Severe acute respiratory syndrome coronavirus‐2 vaccine‐induced B cells aspire to long‐lived connections
Liam Kealy, Kim L. Good‐Jacobson
Immunology and Cell Biology (2022) Vol. 100, Iss. 5, pp. 308-311
Open Access
Liam Kealy, Kim L. Good‐Jacobson
Immunology and Cell Biology (2022) Vol. 100, Iss. 5, pp. 308-311
Open Access
Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of variants-of-concern by Spike RBD-specific memory B cells
Gemma E. Hartley, Emily S.J. Edwards, Nirupama Varese, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Gemma E. Hartley, Emily S.J. Edwards, Nirupama Varese, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Imunomodulação da expressão de PD-1 em monócitos e linfócitos T e B na infecção por SARS-CoV-2
Danielle Rosa Beserra
(2022)
Open Access
Danielle Rosa Beserra
(2022)
Open Access
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
Rapisa Nantanee, Puneyavee Aikphaibul, Peera Jaru-Ampornpan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Rapisa Nantanee, Puneyavee Aikphaibul, Peera Jaru-Ampornpan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
SARS-CoV-2 Infection Generates Long-Lived Memory B Cells Against the Receptor Binding Domain of the Spike Protein
Angéline Rouers, Matthew Zirui Tay, Siew‐Wai Fong, et al.
SSRN Electronic Journal (2021)
Closed Access
Angéline Rouers, Matthew Zirui Tay, Siew‐Wai Fong, et al.
SSRN Electronic Journal (2021)
Closed Access